Ally Financial Inc (ALLY) concluded trading on Wednesday at a closing price of $36.78, with 4.06 million shares of worth about $149.21 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 8.21% during that period and on March 26, 2025 the price saw a loss of about -1.76%. Currently the company’s common shares owned by public are about 305.39M shares, out of which, 303.65M shares are available for trading.
Stock saw a price change of 3.72% in past 5 days and over the past one month there was a price change of 0.85%. Year-to-date (YTD), ALLY shares are showing a performance of 2.14% which decreased to -6.39% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $31.95 but also hit the highest price of $45.46 during that period. The average intraday trading volume for Ally Financial Inc shares is 3.77 million. The stock is currently trading 4.16% above its 20-day simple moving average (SMA20), while that difference is down -0.63% for SMA50 and it goes to -2.91% lower than SMA200.
Ally Financial Inc (NYSE: ALLY) currently have 305.39M outstanding shares and institutions hold larger chunk of about 90.24% of that.
The stock has a current market capitalization of $11.30B and its 3Y-monthly beta is at 1.11. PE ratio of stock for trailing 12 months is 14.16, while it has posted earnings per share of $2.60 in the same period. Its PEG reads 0.36 while making debt-to-equity ratio of 1.38. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALLY, volatility over the week remained 3.24% while standing at 3.56% over the month.
Stock’s fiscal year EPS is expected to rise by 55.07% while it is estimated to increase by 52.55% in next year. EPS is likely to grow at an annualized rate of 39.48% for next 5-years, compared to annual growth of -16.14% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BTIG Research on March 25, 2025 offering a Sell rating for the stock and assigned a target price of $30 to it. On October 21, 2024, Raymond James Upgrade their recommendations, while on October 07, 2024, JP Morgan Upgrade their ratings for the stock with a price target of $40. Stock get a Neutral rating from BTIG Research on September 16, 2024.
